|
KAPA Kairos Pharma Ltd 1962011 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-1,654,000.00 |
| Balance Sheet |
|
Current Assets
|
$4,443,000.00 |
|
Assets
|
$5,744,000.00 |
|
Current Liabilities
|
$431,000.00 |
|
Liabilities
|
$992,000.00 |
|
Equity
|
$5,313,000.00 |
|
Shares Out
|
21411198.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-1,036,000.00 |
| Market Analysis |
Market Cap
|
$6,423,359.40 |
|
Price
|
$0.30 |
|
BVPS
|
0.25 |
|
PB
|
1.20 |
|
EPS
|
-0.08 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:45 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:45 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view KAPA documents filed with the SEC.
KAPA Filings
Clear
